NF1‐09 presents MPNST genetic features such as the inactivation of NF1, CDKN2A, and also TP53, but with PRC2 active and an activating mutation in the PIK3CA gene. This evidence concerns the gene TP53 and malignant peripheral nerve sheath tumor.